4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-3-oxo-N-[(thiophen-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Chemical Structure Depiction of
4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-3-oxo-N-[(thiophen-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-3-oxo-N-[(thiophen-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
Compound characteristics
| Compound ID: | L310-2513 |
| Compound Name: | 4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-6-methyl-3-oxo-N-[(thiophen-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide |
| Molecular Weight: | 448.52 |
| Molecular Formula: | C19 H20 N4 O5 S2 |
| Smiles: | CCc1nc(CN2C(COc3cc(c(C)cc23)S(NCc2cccs2)(=O)=O)=O)no1 |
| Stereo: | ACHIRAL |
| logP: | 2.6561 |
| logD: | 2.6541 |
| logSw: | -3.0614 |
| Hydrogen bond acceptors count: | 11 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 99.45 |
| InChI Key: | GEDJLQMIJWZMGV-UHFFFAOYSA-N |